tiprankstipranks
Trending News
More News >
Takeda Pharmaceutical Co Ltd (TKPHF)
OTHER OTC:TKPHF
US Market
Advertisement

Takeda Pharmaceutical Co (TKPHF) Financial Statements

Compare
35 Followers

Takeda Pharmaceutical Co Financial Overview

Takeda Pharmaceutical Co's market cap is currently $48.35B. The company's EPS TTM is $0.538729; its P/E ratio is 46.32; and it has a dividend yield of 4.70%. Takeda Pharmaceutical Co is scheduled to report earnings on July 30, 2025, and the estimated EPS forecast is $0.33. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 4.58T¥ 4.26T¥ 4.03T¥ 3.57T¥ 3.20T
Gross Profit¥ 2.46T¥ 2.32T¥ 2.30T¥ 2.04T¥ 1.80T
Operating Income¥ 627.54B¥ 531.42B¥ 658.29B¥ 610.50B¥ 447.61B
EBITDA¥ 1.13T¥ 927.95B¥ 1.18T¥ 1.04T¥ 1.07T
Net Income¥ 107.93B¥ 144.07B¥ 317.02B¥ 230.06B¥ 376.00B
Balance Sheet
Cash & Short-Term Investments¥ 385.11B¥ 457.80B¥ 533.53B¥ 849.70B¥ 966.22B
Total Assets¥ 14.25T¥ 15.11T¥ 13.96T¥ 13.18T¥ 12.91T
Total Debt¥ 5.09T¥ 5.46T¥ 4.86T¥ 4.81T¥ 5.07T
Net Debt¥ 4.85T¥ 5.26T¥ 4.63T¥ 3.96T¥ 4.11T
Total Liabilities¥ 7.31T¥ 7.83T¥ 7.60T¥ 7.49T¥ 7.74T
Stockholders' Equity¥ 6.94T¥ 7.27T¥ 6.35T¥ 5.68T¥ 5.17T
Cash Flow
Free Cash Flow¥ 761.70B¥ 464.90B¥ 736.56B¥ 897.97B¥ 793.87B
Operating Cash Flow¥ 962.49B¥ 640.32B¥ 877.22B¥ 1.02T¥ 905.07B
Investing Cash Flow¥ -385.36B¥ -488.21B¥ -615.72B¥ -204.44B¥ 392.04B
Financing Cash Flow¥ -638.44B¥ -254.04B¥ -600.59B¥ -962.06B¥ -981.00B
Currency in JPY

Takeda Pharmaceutical Co Earnings and Revenue History

Takeda Pharmaceutical Co Debt to Assets

Takeda Pharmaceutical Co Cash Flow

Takeda Pharmaceutical Co Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis